Timtim, Ester Irene .
HRN: 25-20-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2024
CEFUROXIME 500MG (TAB)
05/27/2024
06/03/2024
PO
500mg
Bid
SP NSVD; MSAF Thickly
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes